Pages that link to "Q28744417"
Jump to navigation
Jump to search
The following pages link to The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma (Q28744417):
Displaying 24 items.
- Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal (Q26744536) (← links)
- Other targeted drugs in melanoma (Q26775863) (← links)
- Notch signaling: an emerging therapeutic target for cancer treatment (Q26784068) (← links)
- From fly wings to targeted cancer therapies: a centennial for notch signaling (Q27004534) (← links)
- Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases (Q28391383) (← links)
- Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice (Q33895739) (← links)
- Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo (Q36067871) (← links)
- Cancer stem cells and chemoresistance: The smartest survives the raid (Q36730432) (← links)
- Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies (Q36796375) (← links)
- Identification of a Novel Pathogenic Germline KDR Variant in Melanoma. (Q36902033) (← links)
- Chemotherapy in the management of advanced cutaneous malignant melanoma (Q37007984) (← links)
- Anti-myeloma effect of pharmacological inhibition of Notch/gamma-secretase with RO4929097 is mediated by modulation of tumor microenvironment (Q37013225) (← links)
- Hedgehog pathway blockade inhibits melanoma cell growth in vitro and in vivo (Q37370438) (← links)
- Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies (Q37610799) (← links)
- Notch activation stimulates migration of breast cancer cells and promotes tumor growth (Q37690747) (← links)
- Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments (Q37708989) (← links)
- Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. (Q38717772) (← links)
- Gamma secretase inhibitors: a patent review (2013 - 2015). (Q38738605) (← links)
- Approaches for targeting cancer stem cells drug resistance (Q38971795) (← links)
- Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma (Q42317543) (← links)
- Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways. (Q47827202) (← links)
- Targeting Notch signalling pathway of cancer stem cells. (Q52571053) (← links)
- Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model (Q57847240) (← links)
- Long-Term Inhibition of Notch in A-375 Melanoma Cells Enhances Tumor Growth Through the Enhancement of AXIN1, CSNK2A3, and CEBPA2 as Intermediate Genes in Wnt and Notch Pathways (Q97645823) (← links)